RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Related Posts
News
Remedy Biologics is pleased to announce that Dr Colm Galligan has been appointed to its Board of Directors.
karlobrienFebruary 11, 2026
News
Dan Crowley, CEO of RemedyBio, to Speak at the 7th Annual Allogeneic Cell Therapies Summit 2025 in Boston
karlobrienMarch 31, 2025
